AbCellera Biologics Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BAKER BROS. ADVISORS LP | 11/14/2024 | 27.53 M | $71.57 M | 0.00% | 9.34% |
BAILLIE GIFFORD & CO | 11/05/2024 | 12.89 M | $33.53 M | -41.15% | 4.37% |
VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 10.62 M | $27.62 M | 0.00% | 3.60% |
PROSIGHT MANAGEMENT, LP | 11/14/2024 | 9.08 M | $23.61 M | 285.93% | 3.08% |
ORBIMED ADVISORS LLC | 11/14/2024 | 4.18 M | $10.87 M | 0.00% | 1.42% |
ARROWMARK COLORADO HOLDINGS LLC | 11/14/2024 | 4.11 M | $10.67 M | 0.00% | 1.39% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 3.99 M | $10.37 M | 100.00% | 1.35% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 2.95 M | $7.66 M | 70.47% | 1.00% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 2.53 M | $6.59 M | 22.91% | 0.86% |
TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 2.30 M | $5.98 M | 398.16% | 0.78% |
TWO SIGMA ADVISERS, LP | 11/14/2024 | 2.18 M | $5.66 M | 23.39% | 0.74% |
GUARDIAN CAPITAL ADVISORS LP | 11/12/2024 | 1.79 M | $4.59 M | 0.00% | 0.61% |
CITADEL ADVISORS LLC | 11/14/2024 | 1.50 M | $3.90 M | 1.79% | 0.51% |
NOVO HOLDINGS A/S | 10/24/2024 | 1.13 M | $2.93 M | 0.00% | 0.38% |
LAZARD ASSET MANAGEMENT LLC | 11/14/2024 | 1.10 M | $2.85 M | 0.40% | 0.37% |
OPALEYE MANAGEMENT INC. | 11/14/2024 | 800,000 | $2.08 M | 300.00% | 0.27% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 753,887 | $1.96 M | 67.27% | 0.26% |
MORGAN STANLEY | 11/14/2024 | 589,653 | $1.53 M | 6.80% | 0.20% |
INTELLECTUS PARTNERS, LLC | 11/06/2024 | 545,533 | $1.42 M | 0.00% | 0.19% |
D. E. SHAW & CO., INC. | 11/14/2024 | 420,240 | $1.09 M | -9.93% | 0.14% |
ROYAL BANK OF CANADA | 11/14/2024 | 407,384 | $1.06 M | -0.36% | 0.14% |
JPMORGAN CHASE & CO | 11/08/2024 | 355,747 | $924,942 | 6.43% | 0.12% |
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 11/07/2024 | 340,267 | $884,694 | 10.27% | 0.12% |
STATE STREET CORP | 11/14/2024 | 323,229 | $840,395 | 1.47% | 0.11% |
CITIZENS FINANCIAL GROUP INC/RI | 11/08/2024 | 311,890 | $810,914 | 0.00% | 0.11% |
WALLEYE CAPITAL LLC | 11/14/2024 | 256,881 | $667,891 | 100.00% | 0.09% |
GSA CAPITAL PARTNERS LLP | 11/05/2024 | 241,866 | $629,000 | 991.31% | 0.08% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 234,064 | $608,566 | -5.90% | 0.08% |
TD WATERHOUSE CANADA INC. | 11/12/2024 | 232,424 | $594,912 | -5.37% | 0.08% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 205,707 | $534,838 | 114.80% | 0.07% |
PIER 88 INVESTMENT PARTNERS LLC | 11/06/2024 | 195,500 | $508,300 | 20.96% | 0.07% |
SALEM INVESTMENT COUNSELORS INC | 10/15/2024 | 191,150 | $496,990 | 203.41% | 0.06% |
TRUEMARK INVESTMENTS, LLC | 10/16/2024 | 134,414 | $349,476 | 22.24% | 0.05% |
HRT FINANCIAL LP | 11/12/2024 | 129,904 | $337,000 | 100.00% | 0.04% |
FIL LTD | 11/13/2024 | 123,879 | $322,085 | 3.26% | 0.04% |
POLAR ASSET MANAGEMENT PARTNERS INC. | 11/14/2024 | 117,830 | $306,358 | 0.00% | 0.04% |
ENTRYPOINT CAPITAL, LLC | 11/13/2024 | 117,158 | $304,611 | 100.00% | 0.04% |
AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 117,126 | $304,528 | -0.08% | 0.04% |
ARCHPOINT INVESTORS | 11/13/2024 | 115,055 | $299,143 | 0.00% | 0.04% |
ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 114,981 | $298,951 | 100.00% | 0.04% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 113,653 | $295,497 | -63.90% | 0.04% |
JANE STREET GROUP, LLC | 11/15/2024 | 105,952 | $275,475 | -31.54% | 0.04% |
ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 104,254 | $271,049 | -2.09% | 0.04% |
CITADEL ADVISORS LLC | 11/14/2024 | 98,300 | $255,580 | 49.85% | 0.03% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 95,500 | $248,300 | -28.89% | 0.03% |
11/25/2024 | 95,116 | $262,520 | -10.20% | 0.03% | |
DEKABANK DEUTSCHE GIROZENTRALE | 10/24/2024 | 87,000 | $224,000 | 0.00% | 0.03% |
EPIQ CAPITAL GROUP, LLC | 11/14/2024 | 86,291 | $224,357 | 0.00% | 0.03% |
STANSBERRY ASSET MANAGEMENT, LLC | 11/14/2024 | 83,937 | $218,236 | -5.06% | 0.03% |
GROUP ONE TRADING, L.P. | 11/14/2024 | 74,984 | $194,958 | 295.17% | 0.03% |
AbCellera Biologics Inc.institutional Ownership - FAQ's
During the previous two years, 179 institutional investors and hedge funds held shares of AbCellera Biologics Inc.. The most heavily invested institutionals were:
BAKER BROS. ADVISORS LP: 27.53 M
BAILLIE GIFFORD & CO: 12.89 M
VOYA INVESTMENT MANAGEMENT LLC: 10.62 M
Prosight Management, LP: 9.08 M
ORBIMED ADVISORS LLC: 4.18 M
ArrowMark Colorado Holdings LLC: 4.11 M
35.51% of AbCellera Biologics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 116.14 M shares in the last 24 months. This purchase volume represents approximately $329.83 M in transactions.